{
  "CellLine_hpscreg_id": "Genea019",
  "CellLine_alt_names": [
    "SIVF019"
  ],
  "CellLine_cell_line_type": "hESC",
  "CellLine_source_cell_type": "Human pluripotent cell line",
  "CellLine_publication_doi": "10.1016/j.scr.2016.02.008",
  "CellLine_publication_pmid": "",
  "CellLine_publication_title": "Derivation of human embryonic stem cell line Genea019",
  "CellLine_publication_first_author": "Biljana Dumevska",
  "CellLine_publication_last_author": "Uli Schmidt",
  "CellLine_publication_journal": "Stem Cell Research",
  "CellLine_publication_year": 2016,
  "CellLine_donor_age": null,
  "CellLine_donor_sex": "Female",
  "CellLine_donor_disease": "Healthy",
  "CellLine_source_tissue": "Human embryos",
  "CellLine_source": "donor",
  "CellLine_contact_name": "Biljana Dumevska",
  "CellLine_contact_email": "biljana.dumevska@geneabiocells.com",
  "CellLine_contact_phone": "",
  "CellLine_maintainer": "Genea Biocells",
  "CellLine_producer": "Genea Biocells",
  "CellLine_frozen": true,
  "GenomicAlteration_performed": false,
  "GenomicAlteration_mutation_type": "",
  "GenomicAlteration_cytoband": "",
  "GenomicAlteration_delivery_method": "",
  "GenomicAlteration_loci_name": "",
  "GenomicAlteration_loci_start": 0,
  "GenomicAlteration_loci_end": 0,
  "GenomicAlteration_loci_group": "",
  "GenomicAlteration_loci_disease": "",
  "GenomicAlteration_description": "",
  "GenomicAlteration_genotype": "",
  "PluripotencyCharacterisation_cell_type": "Ectoderm",
  "PluripotencyCharacterisation_shown_potency": true,
  "PluripotencyCharacterisation_marker_list": [
    "Nanog",
    "Oct4",
    "Tra1-60",
    "SSEA4"
  ],
  "PluripotencyCharacterisation_method": "Immunofluorescence, Pluritest, Teratoma formation",
  "PluripotencyCharacterisation_differentiation_profile": "in vivo teratoma",
  "ReprogrammingMethod_vector_type": "",
  "ReprogrammingMethod_vector_name": "",
  "ReprogrammingMethod_kit": "",
  "ReprogrammingMethod_detected": false,
  "GenomicCharacterisation_passage_number": 3,
  "GenomicCharacterisation_karyotype": "46, XX",
  "GenomicCharacterisation_karyotype_method": "G-Banding",
  "GenomicCharacterisation_summary": "Karyotyping was performed at passage 3 using G-banding, showing a normal female karyotype with 46, XX.",
  "STR_Results_exists": true,
  "STR_Results_loci": 30,
  "STR_Results_group": "Non-HLA",
  "STR_Results_allele_1": "12,13",
  "STR_Results_allele_2": "29,30",
  "InducedDerivation_i_source_cell_type": "",
  "InducedDerivation_i_cell_origin": "",
  "InducedDerivation_derivation_year": "",
  "InducedDerivation_vector_type": "",
  "InducedDerivation_vector_name": "",
  "InducedDerivation_kit_name": "",
  "EmbryonicDerivation_embryo_stage": "Blastocyst",
  "EmbryonicDerivation_zp_removal_technique": "Pronase",
  "EmbryonicDerivation_cell_seeding": "Plated whole onto mitomycin C inactivated human feeders",
  "EmbryonicDerivation_e_preimplant_genetic_diagnosis": "No mutation; 15 and 18 CAG repeats in HTT gene",
  "Ethics": [
    {
      "ethics_number": "",
      "approval_date": "13 September 2005",
      "institutional_HREC": "Genea Ethics Committee"
    }
  ],
  "MicrobiologyVirologyScreening_performed": true,
  "MicrobiologyVirologyScreening_hiv1": "",
  "MicrobiologyVirologyScreening_hiv2": "",
  "MicrobiologyVirologyScreening_hep_b": "",
  "MicrobiologyVirologyScreening_hep_c": "",
  "MicrobiologyVirologyScreening_mycoplasma": "Negative",
  "MicrobiologyVirologyScreening_other": "",
  "MicrobiologyVirologyScreening_other_result": "",
  "CultureMedium_co2_concentration": 5,
  "CultureMedium_o2_concentration": 21,
  "CultureMedium_passage_method": "Enzymatically",
  "CultureMedium_base_medium": "Standard hESC culture medium with 50 ng/mL Fgf2",
  "CultureMedium_base_coat": "Mitomycin C inactivated human feeders"
}